Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance.
about
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokinesMaturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytesExpression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgeryIMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like InflammationEndotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice.Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection.Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients.mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin toleranceIRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cellsPediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology.Rebuilding immunity in cancer patients.Circulating Porphyromonas gingivalis lipopolysaccharide resets cardiac homeostasis in mice through a matrix metalloproteinase-9-dependent mechanism.Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunityImmunotoxicity and environment: immunodysregulation and systemic inflammation in children.Galactomannan Downregulates the Inflammation Responses in Human Macrophages via NFκB2/p100.Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance.Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation.Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock.Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients.The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytes.Toxoplasma gondii glycosylphosphatidylinositols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages.Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
P2860
Q28260203-7876F2D4-87CF-4B08-95AC-490FE93F2A47Q28269054-8D388A7A-C6CE-4776-A0E7-5C2D1465A589Q28293840-CC3565EC-7F27-477B-B9EF-48A16AD94359Q28551673-39BCCCD7-F1E3-4E84-AC85-206A06982F3AQ34111575-B8A003A0-FB6D-47E0-B392-2D69E44481A4Q34568558-C30D1A44-55D3-4D98-948B-263167079719Q34786821-99B4A477-99B4-42FE-B88A-D6ED676A939CQ35189328-D6DE1C09-C308-4A1C-920B-7A9CDDAB7DB8Q35574274-D1C8C6A5-51D6-4360-9E1C-3FB2F0F6E804Q35908308-27045E28-76FE-4474-80AF-B103BBD77178Q36623286-005E8D7E-F626-4CE8-A2A3-EFCFAE06F82CQ36746486-1CB815A8-1C7E-4FD8-8AD0-3428EC2CB6B4Q36934947-3572E59A-13D6-4782-A991-87D668C4731DQ37244775-57F8537F-9B2A-4EED-9D81-857FA8FFBFFDQ37475149-3927E60A-692E-40A6-B45E-6B8FD3B68773Q39871205-865D0A71-2FA7-4491-BC90-60E36102B283Q40461023-6818C0E1-B3F7-4EE6-B455-35A33F90B208Q41911154-34DF06B8-CF1A-4168-96CC-94D38098F8D0Q42183073-3C14FFD8-5052-446B-9B99-A5AA8FAC6EB7Q42200652-35140D21-9F9B-4C99-987D-AD21C85E0952Q44803821-6C63A615-0F56-46DF-A348-2E74066F47E5Q46043095-3E3977FE-D051-46CD-8B6F-D2B952EFC516Q46473054-DE28329B-4FA8-4EA9-B175-CA0C2D0071B6Q51833479-597516DB-27AB-4C1B-852A-1EAF62C9434CQ52909875-E34F1093-FC57-483C-AA79-AD42590F4FB0
P2860
Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Multiple mechanisms of reduced ...... ession in endotoxin tolerance.
@en
Multiple mechanisms of reduced ...... ession in endotoxin tolerance.
@nl
type
label
Multiple mechanisms of reduced ...... ession in endotoxin tolerance.
@en
Multiple mechanisms of reduced ...... ession in endotoxin tolerance.
@nl
prefLabel
Multiple mechanisms of reduced ...... ession in endotoxin tolerance.
@en
Multiple mechanisms of reduced ...... ession in endotoxin tolerance.
@nl
P2093
P2860
P356
P1476
Multiple mechanisms of reduced ...... ession in endotoxin tolerance.
@en
P2093
Hans-Dieter Volk
Kerstin Wolk
Nigel E A Crompton
Robert Sabat
Stefanie Kunz
P2860
P304
18030-18036
P356
10.1074/JBC.M207714200
P407
P577
2003-03-13T00:00:00Z